{"disease":{"id":"erysipelas","name":"Erysipelas","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":5,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"benzylpenicillin","indication_name":"Erysipelas","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Penicillin G Potassium In Plastic Container","generic_name":"Benzylpenicillin","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"Penicillin-class Antibacterial","quality_score":32,"revenue":null,"mechanism":""},{"drug_id":"bicillin-c-r","indication_name":"Erysipelas","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bicillin C-R","generic_name":"Penicillin G Benzathine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Cell-wall peptidoglycan biosynthesis","drug_class":"Beta-lactam antibiotic","quality_score":10,"revenue":null,"mechanism":"Penicillin G inhibits bacterial cell-wall peptidoglycan biosynthesis, rendering the cell wall osmotically unstable."},{"drug_id":"benzathine-benzylpenicillin","indication_name":"Erysipelas","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bicillin C-R","generic_name":"benzathine benzylpenicillin","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"benzathine benzylpenicillin","quality_score":60,"revenue":null,"mechanism":"Bicillin C-R works by binding to penicillin-binding proteins on bacterial cell walls, preventing them from forming a strong cell wall and ultimately leading to bacterial cell death."},{"drug_id":"penicillin","indication_name":"Erysipelas","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"penicillin","company_name":"Karlstad University","drug_phase":"marketed","molecular_target":"Bacterial penicillin-binding protein, Beta-lactamase, Beta-lactamase TEM","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"phenoxymethylpenicillin","indication_name":"Erysipelas","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Phenoxymethylpenicillin","company_name":"Katarina Hedin","drug_phase":"marketed","molecular_target":"Bacterial penicillin-binding protein, Penicillin-binding protein 1A","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":5,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07104552","title":"Comparing Short to Standard Amoxicillin Course for Erysipelas","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":656,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT01519778","title":"A Phase 2 Safety and Exploratory Skin Lesion Measurement of TR-701 FA Study","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","has_results":true},{"nct_id":"NCT02032654","title":"Duration of ANtibiotic Therapy for CEllulitis","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":151,"lead_sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","has_results":false},{"nct_id":"NCT03917277","title":"Musculoskeletal Ultrasound of the Ankles in Erysipelas-like Erythema of Familial Mediterranean Fever","phase":"NA","overall_status":"UNKNOWN","enrollment_count":15,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT00893048","title":"The Use of Oral Steroids in the Treatment of Cellulitis","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Milton S. Hershey Medical Center","has_results":false}],"total":5},"guidelines":[{"drug_id":"bicillin-l-a","guideline_body":"FDA label","recommendation":"Intramuscular penicillin G benzathine is indicated for mild-to-moderate infections of the upper-respiratory tract due to susceptible streptococci.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"bicillin-l-a","guideline_body":"FDA label","recommendation":"Intramuscular penicillin G benzathine is indicated for mild-to-moderate infections of the upper-respiratory tract due to susceptible streptococci.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"bicillin-l-a","guideline_body":"FDA label","recommendation":"Intramuscular penicillin G benzathine is indicated for mild-to-moderate infections of the upper-respiratory tract due to susceptible streptococci.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"bicillin-l-a","guideline_body":"FDA label","recommendation":"Intramuscular penicillin G benzathine is indicated for mild-to-moderate infections of the upper-respiratory tract due to susceptible streptococci.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"bicillin-l-a","guideline_body":"FDA label","recommendation":"Intramuscular penicillin G benzathine is indicated for mild-to-moderate infections of the upper-respiratory tract due to susceptible streptococci.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"bicillin-l-a","guideline_body":"FDA label","recommendation":"Intramuscular penicillin G benzathine is indicated for mild-to-moderate infections of the upper-respiratory tract due to susceptible streptococci.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"bicillin-l-a","guideline_body":"FDA label","recommendation":"Intramuscular penicillin G benzathine is indicated for the treatment of syphilis, yaws, bejel, and pinta.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"bicillin-c-r-900-300","guideline_body":"FDA label","recommendation":"Intramuscular penicillin G benzathine is indicated for mild-to-moderate infections of the upper-respiratory tract due to susceptible streptococci.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"bicillin-c-r-900-300","guideline_body":"FDA label","recommendation":"Intramuscular penicillin G benzathine is indicated for mild-to-moderate infections of the upper-respiratory tract due to susceptible streptococci.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"bicillin-c-r-900-300","guideline_body":"FDA label","recommendation":"Intramuscular penicillin G benzathine is indicated for mild-to-moderate infections of the upper-respiratory tract due to susceptible streptococci.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"bicillin-c-r-900-300","guideline_body":"FDA label","recommendation":"Intramuscular penicillin G benzathine is indicated for mild-to-moderate infections of the upper-respiratory tract due to susceptible streptococci.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"bicillin-c-r-900-300","guideline_body":"FDA label","recommendation":"Intramuscular penicillin G benzathine is indicated for mild-to-moderate infections of the upper-respiratory tract due to susceptible streptococci.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"bicillin-c-r-900-300","guideline_body":"FDA label","recommendation":"Intramuscular penicillin G benzathine is indicated for mild-to-moderate infections of the upper-respiratory tract due to susceptible streptococci.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"bicillin-c-r-900-300","guideline_body":"FDA label","recommendation":"Intramuscular penicillin G benzathine is indicated for venereal infections including syphilis, yaws, bejel, and pinta.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null}],"source":"Drug Landscape verified database"}